Phase 3 ALS Clinical Trials
19 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–19 of 19 trials
Recruiting
Phase 3
Antenatal Magnesium Sulphate in High-Risk Preterm Patients
Cerebral PalsyMagnesium Sulfate Overdose
Cairo University138 enrolled1 locationNCT07524972
Recruiting
Phase 3
Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy
Obstetrical Brachial Plexus Palsy
University Hospital, Brest62 enrolled7 locationsNCT03198702
Recruiting
Phase 2Phase 3
Therapeutic Photobiomodulation and Tretament of Spasticity
Muscle SpasticityCerebral PalsyPhotobiomodulation+1 more
University of Nove de Julho28 enrolled2 locationsNCT06536751
Recruiting
Phase 2Phase 3
Wereables for Upper Limb Functionality in Hemiparesis
Unilateral Cerebral Palsy
Universidade da Coruña40 enrolled1 locationNCT06872736
Completed
Phase 3
A pilot study of gabapentin for managing pain in children with dystonic cerebral palsy
Dystonic cerebral palsy
Murdoch Childrens Research Institute20 enrolled4 locationsACTRN12616000366459
Recruiting
Phase 3
Bell's Palsy in Children: A Multi-centre, double-blind, Randomised, Placebo-controlled Trial to Determine Whether Prednisolone Improves Recovery at 1 Month.
Bell's Palsy
Franz Babl540 enrolled9 locationsACTRN12615000563561
Completed
Phase 2Phase 3
21 day trial into the weight reduction effects of supplementation with 1g and 500mg SolaThin.
weight and appetite in overweight and obese individuals
CYVEX NUTRITION, INC60 enrolled1 locationACTRN12612000198820
Not Yet Recruiting
Phase 3Phase 4
Can an acute dosage of Bacopa Monniera (brahmi) improve cognition and cardiovascular function in a healthy population
Cognitive function in healthy individualsCardiovascular function in health individuals
Swinburne University of technology30 enrolled1 locationACTRN12611001234909
Completed
Phase 3Phase 4
Can an acute dosage of Bacopa Monniera (brahmi) improve cognition, cardiovascular function and stress in an elderly population
Cognitive function in healthy elderly individualsCardiovascular function in healthy elderly individualsStress
Swinburne University20 enrolled1 locationACTRN12611001230943
Completed
Phase 3
MAGENTA - Magnesium Sulphate at 30 to 34 weeks' gestational age: Neuroprotection Trial
Complications of preterm infantCerebral PalsyNeuroprotection
University of Adelaide1,676 enrolled1 locationACTRN12611000491965
Active
Phase 3
A study to evaluate whether increased codeine levels are seen when both codeine and ketamine are given in small doses to well volunteers.
The possibility that ketamine,an anaesthetic medication but which is also used at much lower doses, to help try and control severe chronic nerve pain, may increase the effective blood levels of opioids such as codeine or morphine that are often given in conjunction with ketamine.This study is looking at drug metabolism not pain management or anaesthesiology
Flinders University- Department of Clinical Pharmacology10 enrolled1 locationACTRN12610000283077
Recruiting
Phase 3Phase 4
Can an acute dosage of Bacopa Monniera (brahmi) improve cognition, cardiovascular function and stress in a healthy older population
Cognitive function in healthy older individualsCardiovascular function in healthy older individualsStress
Swinburne University32 enrolled1 locationACTRN12609000717257
Completed
Phase 3
An exploration of the antioxidant, immunomodulatory, and anti-inflammatory activities of Ambrotose in healthy individuals.
Immune system function in healthy individualsAntioxidant levels in healthy individuals
Mannatech, Inc60 enrolled1 locationACTRN12608000078358
Completed
Phase 2Phase 3
The acceptability, safety and tolerability of combined methadone-naloxone in methadone maintained individuals aged between 18 - 65
Participants are opiod dependant and methadone maintained individuals aged between 18-65
Langton Centre10 enrolled1 locationACTRN12608000024347
Active
Phase 3
The effect of botulinum toxin-A on the functional ability of the very young child with spastic hemiplegia due to cerebral palsy.
spasticity in children with cerebral palsy
Sarah Love30 enrolled1 locationACTRN12607000484448
Completed
Phase 3
A randomised controlled trial to determine the optimum frequency of Botulinum Toxin injections to the calf in children with cerebral palsy
Cerebral palsy in children
The Royal Children's Hospital, Melbourne, Victoria40 enrolled1 locationACTRN12607000326493
Completed
Phase 3
Interactive Educational Workshops and Follow-up Support: A Strategy to Facilitate Allied Health Clinicians' Routine Measurement of Clinical Outcomes
Allied health professionals
University of Western Sydney, Dr Catherine Cook, Dr Annie McCluskey & Dr Natasha Lannin108 enrolled1 locationACTRN12606000500550
Recruiting
Phase 3
"Thumbs up!"
Cerebral Palsy
Dr Lisa Copeland40 enrolled1 locationACTRN12606000492550
Not Yet Recruiting
Phase 3
Motor Skills Project
Children with physical disabilities - cerebral palsyDown's syndrome
Australian Physiotherapy Association20 enrolled1 locationACTRN12605000749606